APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cells

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Selected research

Industry Growth & Trends

Global Stem Cells Industry Growth and Trends Forecast to 2032

1 January 2026111 pages

Choose your research edition.

Industry ResearchStem Cells Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cells Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cells Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cells Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

According to APO Research, the global Stem Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Stem Cells market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Stem Cells market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Stem Cells market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Stem Cells.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Stem Cells market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Stem Cells Market by Company

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

Medi-post

JCR Pharmaceutical

MolMed

Pharmicell

Anterogen

Takeda (TiGenix)

CBR

ViaCord

Esperite

LifeCell

CCBC

VCANBIO

BOYA LIFE

Beike Biotechnology

International Medical

Stem Cells Segment by Type

Stem Cell Storage

Stem Cell Pharmaceutical and Treatment

Stem Cells Segment by Application

Diseases of the Central Nervous System

Cardiovascular Disease

Diabetes

Cancer

Genetic Diseases

Autoimmune Disease

Bone and Cartilage Repair

Other

Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Stem Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Stem Cells Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Stem Cells Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Stem Cells Market Share by Region (2021-2026) Table 4. Global Stem Cells Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Stem Cells Market Share by Region (2027-2032) Table 6. Global Stem Cells Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Stem Cells Market Size Share by Type (2021-2026) Table 9. Global Stem Cells Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Stem Cells Market Size Share Forecasted by Type (2027-2032) Table 11. North America Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Stem Cells Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Stem Cells Market Size Share by Application (2021-2026) Table 24. Global Stem Cells Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Stem Cells Market Size Share Forecasted by Application (2027-2032) Table 26. North America Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Stem Cells Industry Trends Table 37. Stem Cells Industry Drivers Table 38. Stem Cells Industry Opportunities and Challenges Table 39. Stem Cells Industry Restraints Table 40. Global Stem Cells Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Stem Cells Revenue Market Share by Company (2021-2026) Table 42. Global Stem Cells Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Stem Cells Key Company Headquarters & Area Served Table 44. Global Stem Cells Company, Product Type & Application Table 45. Global Stem Cells Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Osiris Therapeutics Company Information Table 49. Osiris Therapeutics Business Overview Table 50. Osiris Therapeutics Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Osiris Therapeutics Stem Cells Product Portfolio Table 52. Osiris Therapeutics Recent Development Table 53. NuVasive Company Information Table 54. NuVasive Business Overview Table 55. NuVasive Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. NuVasive Stem Cells Product Portfolio Table 57. NuVasive Recent Development Table 58. Chiesi Pharmaceuticals Company Information Table 59. Chiesi Pharmaceuticals Business Overview Table 60. Chiesi Pharmaceuticals Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Chiesi Pharmaceuticals Stem Cells Product Portfolio Table 62. Chiesi Pharmaceuticals Recent Development Table 63. Medi-post Company Information Table 64. Medi-post Business Overview Table 65. Medi-post Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Medi-post Stem Cells Product Portfolio Table 67. Medi-post Recent Development Table 68. JCR Pharmaceutical Company Information Table 69. JCR Pharmaceutical Business Overview Table 70. JCR Pharmaceutical Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. JCR Pharmaceutical Stem Cells Product Portfolio Table 72. JCR Pharmaceutical Recent Development Table 73. MolMed Company Information Table 74. MolMed Business Overview Table 75. MolMed Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. MolMed Stem Cells Product Portfolio Table 77. MolMed Recent Development Table 78. Pharmicell Company Information Table 79. Pharmicell Business Overview Table 80. Pharmicell Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pharmicell Stem Cells Product Portfolio Table 82. Pharmicell Recent Development Table 83. Anterogen Company Information Table 84. Anterogen Business Overview Table 85. Anterogen Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Anterogen Stem Cells Product Portfolio Table 87. Anterogen Recent Development Table 88. Takeda (TiGenix) Company Information Table 89. Takeda (TiGenix) Business Overview Table 90. Takeda (TiGenix) Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Takeda (TiGenix) Stem Cells Product Portfolio Table 92. Takeda (TiGenix) Recent Development Table 93. CBR Company Information Table 94. CBR Business Overview Table 95. CBR Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. CBR Stem Cells Product Portfolio Table 97. CBR Recent Development Table 98. ViaCord Company Information Table 99. ViaCord Business Overview Table 100. ViaCord Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. ViaCord Stem Cells Product Portfolio Table 102. ViaCord Recent Development Table 103. Esperite Company Information Table 104. Esperite Business Overview Table 105. Esperite Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Esperite Stem Cells Product Portfolio Table 107. Esperite Recent Development Table 108. LifeCell Company Information Table 109. LifeCell Business Overview Table 110. LifeCell Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. LifeCell Stem Cells Product Portfolio Table 112. LifeCell Recent Development Table 113. CCBC Company Information Table 114. CCBC Business Overview Table 115. CCBC Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. CCBC Stem Cells Product Portfolio Table 117. CCBC Recent Development Table 118. VCANBIO Company Information Table 119. VCANBIO Business Overview Table 120. VCANBIO Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. VCANBIO Stem Cells Product Portfolio Table 122. VCANBIO Recent Development Table 123. BOYA LIFE Company Information Table 124. BOYA LIFE Business Overview Table 125. BOYA LIFE Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. BOYA LIFE Stem Cells Product Portfolio Table 127. BOYA LIFE Recent Development Table 128. Beike Biotechnology Company Information Table 129. Beike Biotechnology Business Overview Table 130. Beike Biotechnology Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Beike Biotechnology Stem Cells Product Portfolio Table 132. Beike Biotechnology Recent Development Table 133. International Medical Company Information Table 134. International Medical Business Overview Table 135. International Medical Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. International Medical Stem Cells Product Portfolio Table 137. International Medical Recent Development Table 138. North America Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Stem Cells Market Share by Country (2021-2026) Table 141. North America Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Stem Cells Market Share Forecast by Country (2027-2032) Table 143. Europe Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Stem Cells Market Share by Country (2021-2026) Table 146. Europe Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Stem Cells Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Stem Cells Market Share by Country (2021-2026) Table 151. Asia-Pacific Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Stem Cells Market Share Forecast by Country (2027-2032) Table 153. Latin America Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Stem Cells Market Share by Country (2021-2026) Table 156. Latin America Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Stem Cells Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Stem Cells Market Share by Country (2021-2026) Table 161. Middle East & Africa Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Stem Cells Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Stem Cells Product Image Figure 3. Global Stem Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Stem Cells Market Size (2021-2032) & (US$ Million) Figure 5. Global Stem Cells Market Share by Region: 2025 VS 2032 Figure 6. Global Stem Cells Market Share by Region (2021-2032) Figure 7. North America Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Stem Cell Storage Image Figure 13. Global Stem Cell Storage Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Stem Cell Pharmaceutical and Treatment Image Figure 15. Global Stem Cell Pharmaceutical and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Stem Cells Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Stem Cells Market Share by Type 2025 VS 2032 Figure 18. North America Stem Cells Market Size Share by Type (2021-2032) Figure 19. Europe Stem Cells Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Stem Cells Market Size Share by Type (2021-2032) Figure 21. Latin America Stem Cells Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Stem Cells Market Size Share by Type (2021-2032) Figure 23. Diseases of the Central Nervous System Image Figure 24. Global Diseases of the Central Nervous System Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Cardiovascular Disease Image Figure 26. Global Cardiovascular Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Diabetes Image Figure 28. Global Diabetes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cancer Image Figure 30. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Genetic Diseases Image Figure 32. Global Genetic Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Autoimmune Disease Image Figure 34. Global Autoimmune Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Bone and Cartilage Repair Image Figure 36. Global Bone and Cartilage Repair Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Other Image Figure 38. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Stem Cells Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Stem Cells Market Share by Application 2025 VS 2032 Figure 41. North America Stem Cells Market Size Share by Application (2021-2032) Figure 42. Europe Stem Cells Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Stem Cells Market Size Share by Application (2021-2032) Figure 44. Latin America Stem Cells Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Stem Cells Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Stem Cells Market Share by Country (2021-2032) Figure 51. Europe Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Stem Cells Market Share by Country (2021-2032) Figure 54. Asia-Pacific Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Stem Cells Market Share by Country (2021-2032) Figure 57. Latin America Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Stem Cells Market Share by Country (2021-2032) Figure 60. Middle East & Africa Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Stem Cells Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Storage
  • Stem Cell Pharmaceutical and Treatment
Applications
  • Diseases of the Central Nervous System
  • Cardiovascular Disease
  • Diabetes
  • Cancer
  • Genetic Diseases
  • Autoimmune Disease
  • Bone and Cartilage Repair
  • Other
Companies covered
  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • Medi-post
  • JCR Pharmaceutical
  • MolMed
  • Pharmicell
  • Anterogen
  • Takeda (TiGenix)
  • CBR
  • ViaCord
  • Esperite
  • LifeCell
  • CCBC
  • VCANBIO
  • BOYA LIFE
  • Beike Biotechnology
  • International Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Stem Cells Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Stem Cells Market Size by Region (2021-2032)
  5. 1.4.1 Global Stem Cells Market Size by Region (2021-2026)
  6. 1.4.2 Global Stem Cells Market Size by Region (2027-2032)
  7. 1.5 Key Regions Stem Cells Market Size (2021-2032)
  8. 1.5.1 North America Stem Cells Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Stem Cells Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Stem Cells Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Stem Cells Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Stem Cells Market Size Growth Rate (2021-2032)
2 Stem Cells Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Stem Cell Storage
  3. 2.1.2 Stem Cell Pharmaceutical and Treatment
  4. 2.2 Global Stem Cells Market Size by Type
  5. 2.2.1 Global Stem Cells Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Stem Cells Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Stem Cells Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Stem Cells Market Size by Regions
  9. 2.3.1 North America Stem Cells Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Stem Cells Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Stem Cells Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Stem Cells Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Stem Cells Market Size Breakdown by Type (2021-2026)
3 Stem Cells Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Diseases of the Central Nervous System
  3. 3.1.2 Cardiovascular Disease
  4. 3.1.3 Diabetes
  5. 3.1.4 Cancer
  6. 3.1.5 Genetic Diseases
  7. 3.1.6 Autoimmune Disease
  8. 3.1.7 Bone and Cartilage Repair
  9. 3.1.8 Other
  10. 3.2 Global Stem Cells Market Size by Application
  11. 3.2.1 Global Stem Cells Market Size Overview by Application (2021-2032)
  12. 3.2.2 Global Stem Cells Historic Market Size Review by Application (2021-2026)
  13. 3.2.3 Global Stem Cells Market Size Forecasted by Application (2027-2032)
  14. 3.3 Global Stem Cells Market Size by Regions
  15. 3.3.1 North America Stem Cells Market Size Breakdown by Application (2021-2026)
  16. 3.3.2 Europe Stem Cells Market Size Breakdown by Application (2021-2026)
  17. 3.3.3 Asia-Pacific Stem Cells Market Size Breakdown by Application (2021-2026)
  18. 3.3.4 South America Stem Cells Market Size Breakdown by Application (2021-2026)
  19. 3.3.5 Middle East and Africa Stem Cells Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Stem Cells Industry Trends
  2. 4.2 Stem Cells Industry Drivers
  3. 4.3 Stem Cells Industry Opportunities and Challenges
  4. 4.4 Stem Cells Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Stem Cells Revenue (2021-2026)
  2. 5.2 Global Stem Cells Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Stem Cells Key Company Headquarters & Area Served
  4. 5.4 Global Stem Cells Company, Product Type & Application
  5. 5.5 Global Stem Cells Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Stem Cells Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Stem Cells Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Osiris Therapeutics
  2. 6.1.1 Osiris Therapeutics Company Information
  3. 6.1.2 Osiris Therapeutics Business Overview
  4. 6.1.3 Osiris Therapeutics Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Osiris Therapeutics Stem Cells Product Portfolio
  6. 6.1.5 Osiris Therapeutics Recent Developments
  7. 6.2 NuVasive
  8. 6.2.1 NuVasive Company Information
  9. 6.2.2 NuVasive Business Overview
  10. 6.2.3 NuVasive Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 NuVasive Stem Cells Product Portfolio
  12. 6.2.5 NuVasive Recent Developments
  13. 6.3 Chiesi Pharmaceuticals
  14. 6.3.1 Chiesi Pharmaceuticals Company Information
  15. 6.3.2 Chiesi Pharmaceuticals Business Overview
  16. 6.3.3 Chiesi Pharmaceuticals Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
  18. 6.3.5 Chiesi Pharmaceuticals Recent Developments
  19. 6.4 Medi-post
  20. 6.4.1 Medi-post Company Information
  21. 6.4.2 Medi-post Business Overview
  22. 6.4.3 Medi-post Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Medi-post Stem Cells Product Portfolio
  24. 6.4.5 Medi-post Recent Developments
  25. 6.5 JCR Pharmaceutical
  26. 6.5.1 JCR Pharmaceutical Company Information
  27. 6.5.2 JCR Pharmaceutical Business Overview
  28. 6.5.3 JCR Pharmaceutical Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
  30. 6.5.5 JCR Pharmaceutical Recent Developments
  31. 6.6 MolMed
  32. 6.6.1 MolMed Company Information
  33. 6.6.2 MolMed Business Overview
  34. 6.6.3 MolMed Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 MolMed Stem Cells Product Portfolio
  36. 6.6.5 MolMed Recent Developments
  37. 6.7 Pharmicell
  38. 6.7.1 Pharmicell Company Information
  39. 6.7.2 Pharmicell Business Overview
  40. 6.7.3 Pharmicell Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pharmicell Stem Cells Product Portfolio
  42. 6.7.5 Pharmicell Recent Developments
  43. 6.8 Anterogen
  44. 6.8.1 Anterogen Company Information
  45. 6.8.2 Anterogen Business Overview
  46. 6.8.3 Anterogen Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Anterogen Stem Cells Product Portfolio
  48. 6.8.5 Anterogen Recent Developments
  49. 6.9 Takeda (TiGenix)
  50. 6.9.1 Takeda (TiGenix) Company Information
  51. 6.9.2 Takeda (TiGenix) Business Overview
  52. 6.9.3 Takeda (TiGenix) Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
  54. 6.9.5 Takeda (TiGenix) Recent Developments
  55. 6.10 CBR
  56. 6.10.1 CBR Company Information
  57. 6.10.2 CBR Business Overview
  58. 6.10.3 CBR Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 CBR Stem Cells Product Portfolio
  60. 6.10.5 CBR Recent Developments
  61. 6.11 ViaCord
  62. 6.11.1 ViaCord Company Information
  63. 6.11.2 ViaCord Business Overview
  64. 6.11.3 ViaCord Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 ViaCord Stem Cells Product Portfolio
  66. 6.11.5 ViaCord Recent Developments
  67. 6.12 Esperite
  68. 6.12.1 Esperite Company Information
  69. 6.12.2 Esperite Business Overview
  70. 6.12.3 Esperite Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Esperite Stem Cells Product Portfolio
  72. 6.12.5 Esperite Recent Developments
  73. 6.13 LifeCell
  74. 6.13.1 LifeCell Company Information
  75. 6.13.2 LifeCell Business Overview
  76. 6.13.3 LifeCell Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 LifeCell Stem Cells Product Portfolio
  78. 6.13.5 LifeCell Recent Developments
  79. 6.14 CCBC
  80. 6.14.1 CCBC Company Information
  81. 6.14.2 CCBC Business Overview
  82. 6.14.3 CCBC Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 CCBC Stem Cells Product Portfolio
  84. 6.14.5 CCBC Recent Developments
  85. 6.15 VCANBIO
  86. 6.15.1 VCANBIO Company Information
  87. 6.15.2 VCANBIO Business Overview
  88. 6.15.3 VCANBIO Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 VCANBIO Stem Cells Product Portfolio
  90. 6.15.5 VCANBIO Recent Developments
  91. 6.16 BOYA LIFE
  92. 6.16.1 BOYA LIFE Company Information
  93. 6.16.2 BOYA LIFE Business Overview
  94. 6.16.3 BOYA LIFE Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 BOYA LIFE Stem Cells Product Portfolio
  96. 6.16.5 BOYA LIFE Recent Developments
  97. 6.17 Beike Biotechnology
  98. 6.17.1 Beike Biotechnology Company Information
  99. 6.17.2 Beike Biotechnology Business Overview
  100. 6.17.3 Beike Biotechnology Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Beike Biotechnology Stem Cells Product Portfolio
  102. 6.17.5 Beike Biotechnology Recent Developments
  103. 6.18 International Medical
  104. 6.18.1 International Medical Company Information
  105. 6.18.2 International Medical Business Overview
  106. 6.18.3 International Medical Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 International Medical Stem Cells Product Portfolio
  108. 6.18.5 International Medical Recent Developments
7 North America
  1. 7.1 North America Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Stem Cells Market Size by Country (2021-2026)
  3. 7.3 North America Stem Cells Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Stem Cells Market Size by Country (2021-2026)
  3. 8.3 Europe Stem Cells Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Stem Cells Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Stem Cells Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Stem Cells Market Size by Country (2021-2026)
  3. 10.3 South America Stem Cells Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Stem Cells Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Stem Cells Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst